Painless gastroscope
Conditions
Interventions
Group A:Alfentanil 3ug/kg + propofol 2mg/kg
Group B:Alfentanil 5ug/kg + propofol 2mg/kg
Group C:Alfentanil 7ug/kg + propofol 2mg/kg
Group D:Alfentanil 9ug/kg + propofol 2mg/kg
Sponsors
Affiliated Hospital of Guizhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. From October 2020 to January 2021, 200 outpatients of the Affiliated Hospital of Guizhou Medical University and the people's Hospital of Xixiu District, Anshun City planned to undergo painless gastroscopy; 2. ASA grade I - II patients; 3. BMI 18-28 kg / m2; 4. Patients aged 18-60 years were not limited in gender; 5. The patients who clearly understood and voluntarily participated in the study signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with obvious respiratory and circulatory dysfunction, abnormal blood routine and biochemical indexes before operation; 2. The patients who were allergic to the drugs in this study; 3. Patients with severe neuropsychiatric diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of induction for the first time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anesthesia induction time;Changes of NIBP, HR, SPO2 and RR;Additional times of propofol;Patient awakening time;Operation time;Incidence of injection pain;The time for the subjects to reach the discharge standard after the end of the operation.; | — |
Countries
China
Contacts
Public ContactChen Jiejuan
Affiliated Hospital of Guizhou Medical University
Outcome results
None listed